[1] 陈辉, 贾玉艳, 黄粤等. 地中海贫血基因治疗进展和现状[J]. 广西医科大学学报, 2024, 41(1): 1-10. DOI: 10.16190/j.cnki.45-1211/r.2024.01.001.
[2] 张婷婷, 徐湘民. 地中海贫血预防和诊疗技术进展[J]. 广东医学, 2023, 44(10):1189-1193. DOI: 10.13820/j.cnki.gdyx.20232681.
[3] 沈璇, 莫俊, 任峻青, 等.遵义地区5101例地中海贫血筛查情况及基因突变类型分析[J].中国妇幼保健, 2024, 39(4): 739-743. DOI: 10.19829/j.zgfybj.issn.1001-4411.2024. 04.041.
[4] 全健, 刘金明, 梁春燕, 等. 医院-社区联动管理模式在地中海贫血育龄妇女优生优育管理中的应用效果[J]. 广西医学, 2022, 44(13): 1496-1499, 1504. DOI: 10.11675/j.issn.0253-4304.2022.13.13
[5] Zhuang J, Chen C, Fu W, et al. Third-generation sequencing as a new comprehensive technology for identifying rare α- and β-globin gene variants in thalassemia Alleles in the Chinese population [J]. Arch Pathol Lab Med, 2023, 147(2): 208-214. DOI: 10.5858/arpa.2021-0510-OA.
[6] Zhuang J, Zhang N, Wang Y, et al. Molecular characterization analysis of thalassemia and hemoglobinopathy in Quanzhou, Southeast China: a large-scale retrospective study [J]. Front Genet, 2021; 12: 727233. DOI: 10.3389/fgene.2021.727233.
[7] Zheng X, Bao Y, Wu Q, et al. Genetic epidemiology of thalassemia in couples of childbearing age: over 6 years of a thalassemia intervention project[J]. Mol Biol Rep, 2024, 51(1):138. DOI: 10.1007/s11033-023-09091-z.
[8] Xu A, Chen W, Xie W, et al. Hemoglobin variants in southern China: results obtained during the measurement of glycated hemoglobin in a large population[J]. Clin Chem Lab Med, 2020, 59(1): 227-232. DOI: 10.1515/cclm-2020-0767.
[9] Wang M, Zhang X, Zhao Y, et al. Prevalence and genetic analysis of thalassemia in childbearing age population of Hainan, The Free Trade Island in Southern China [J]. J Clin Lab Anal, 2022, 36(3): e24260. DOI:10.1002/jcla.24260.
[10] Yang Y, Li DZ, He P. Hb Dapu (HBA2: c.52G > T): a novel nondeletional α-thalassemia mutation [J]. Hemoglobin, 2016, 40(4): 264-266. DOI: 10.1080/03630269.2016. 1187164.
[11] Zhong Z, Guan Z, Chen D, et al. Molecular analysis and clinical significance of hemoglobin Quong Sze in Huizhou city, Southern China [J]. Taiwan J Obstet Gynecol, 2023, 62(5): 709-712. DOI:10.1016/j.tjog.2023.07.012.
[12] Al-Allawi NA, Al-Mousawi BM, Badi AI, et al. The spectrum of β-thalassemia mutations in Baghdad, Central Iraq[J]. Hemoglobin, 2013, 37(5): 444-453. DOI: 10.3109/03630269.2013.810641.
[13] Farra C, Abdouni L, Souaid M, et al. The spectrum of β-thalassemia mutations in the population migration in Lebanon: a 6-year retrospective study [J]. Hemoglobin, 2021, 45(6): 365-370. DOI: 10.1080/03630269.2021. 1920975.
[14] Chen Z, Shao L, Jiang M, et al. Identification of a rare compound heterozygous hemoglobin variant β0-thal [β17(A14) Lys>Stop, HBB: c.52A>T] and Hb J-Lome [β59(E3) Lys>Asn, HBB: c.180G>C] [J]. Hematology, 2022, 27(1): 946-950. DOI:10.1080/16078454.2022.2114672.
[15] Rai DK, Landin B, Griffiths WJ, et al. Characterization of the elusive disulfide bridge forming human Hb variant: Hb Ta-Li beta83 (EF7)Gly --> Cys by electrospray mass spectrometry[J]. J Am Soc Mass Spectrom, 2002, 13(2):187-191. DOI:10.1016/s1044-0305(01)00349-x.
[16] Chen M, Huang H, Chen L, et al. First report of the spectrum of δ-globin gene mutations among women of reproductive age in Fujian area-discrimination of δ-thalassemia, α-thalassemia, and iron deficiency anemia[J]. J Clin Lab Anal, 2020, 34(11): e23479. DOI:10.1002/jcla.23479.
[17] Singha K, Fucharoen G, Fucharoen S. δ-hemoglobino- pathies in Thailand: screening, molecular basis, genotype-phenotype interaction, and implication for prevention and control of thalassemia [J]. Ann Hematol, 2021, 100(8): 1953-1963. DOI:10.1007/s00277-021- 04510-2.
[18] 王婵, 黄邓高, 冯女,等. 5636例疑似地中海贫血样本的异常血红蛋白分子特征及外周血参数分析[J]. 海南医学, 2024, 35(4): 521-526. DOI:10.3969/j.issn.1003-6350. 2024.04.014.
[19] 张思雯, 徐两蒲, 黄海龙. 珠蛋白生成障碍性贫血患者外周血中蛋白质与非编码RNA作为潜在生物标志物的研究进展[J]. 检验医学与临床, 2023, 20(8): 1130-1135. DOI:10.3969/j.issn.1672-9455.2023.08.025.
[20] 巫娟, 陈宋钦, 倪仰鹏,等. 揭阳地区儿童珠蛋白生成障碍性贫血基因检测结果分析[J]. 检验医学与临床, 2022, 19(16): 2228-2230. DOI: 10.3969/j.issn.1672-9455. 2022.16.017.
[21] 李静, 罗李莉, 郑薇,等. 轻型地中海贫血孕妇血液学指标及妊娠结局的分析[J]. 中国医刊, 2023, 58(9): 1007-1011. DOI: 10.3969/j.issn.1008-1070.2023.09.023.
[22] 廖桂萍, 李静, 周天红,等. 中间型/重型β地中海贫血合并自身免疫性溶血性贫血的临床特点分析[J]. 中国临床新医学, 2022, 15(11): 1030-1034. DOI: 10.3969/j.issn.1674- 3806.2022.11.07.
[23] 李智, 翟露, 宾娟, 等. 广西重型β-地中海贫血患儿生活质量情况及其影响因素分析[J].内科, 2023, 18(4): 377-381. DOI:10.16121/j.cnki.cn45-1347/r.2023.04.16.
[24] 何克斌. 重型β-地中海贫血患儿血浆抗凝血酶Ⅲ、D-二聚体与输血量、铁过载的相关性研究[D]. 百色:右江民族医学院, 2023. DOI:10.27908/d.cnki.gymzy.2023.000043.
[25] 窦倩如, 曹霞, 黄翠敏, 等. 海南省孕前及孕期地中海贫血筛查方案评价及优化研究[J].中国热带医学, 2023, 23(10): 1088-1093. DOI:10.13604/j.cnki.46-1064/r.2023.10.13.
[26] 陈明发, 黄闽忠, 林泉, 等. 中国福建南平地区地中海贫血基因突变类型研究[J]. 中国实验血液学杂志, 2020, 28(03): 918-926. DOI:10.19746/j.cnki.issn1009-2137. 2020.03.033.
|